{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:42:23Z","timestamp":1757781743646,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K15359","17K09898"],"award-info":[{"award-number":["15K15359","17K09898"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18cm0106505h"],"award-info":[{"award-number":["18cm0106505h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12185-018-02576-9","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T12:50:08Z","timestamp":1547124608000},"page":"309-318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prominence of nestin-expressing Schwann cells in bone marrow of patients with myelodysplastic syndromes with severe fibrosis"],"prefix":"10.1007","volume":"109","author":[{"given":"Luan","family":"Cao-Sy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoshi","family":"Obara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayasu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Nannya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamiko","family":"Sakata-Yanagimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Nishikii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7803-7338","authenticated-orcid":false,"given":"Shigeru","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"2576_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S Mendez-Ferrer","year":"2010","unstructured":"Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466:829\u201334.","journal-title":"Nature"},{"key":"2576_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0092-8674(90)90662-X","volume":"60","author":"U Lendahl","year":"1990","unstructured":"Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell. 1990;60:585\u201395.","journal-title":"Cell"},{"key":"2576_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.276.5309.66","volume":"276","author":"R McKay","year":"1997","unstructured":"McKay R. Stem cells in the central nervous system. Science. 1997;276:66\u201371.","journal-title":"Science"},{"key":"2576_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature12612","volume":"502","author":"Y Kunisaki","year":"2013","unstructured":"Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature. 2013;502:637\u201343.","journal-title":"Nature"},{"key":"2576_CR5","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cell.2011.09.053","volume":"147","author":"S Yamazaki","year":"2011","unstructured":"Yamazaki S, Ema H, Karlsson G, Yamaguchi T, Miyoshi H, Shioda S, et al. Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell. 2011;147:1146\u201358.","journal-title":"Cell"},{"key":"2576_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.stem.2014.06.020","volume":"15","author":"M Hanoun","year":"2014","unstructured":"Hanoun M, Zhang D, Mizoguchi T, Pinho S, Pierce H, Kunisaki Y, et al. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem cell. 2014;15:365\u201375.","journal-title":"Cell Stem cell"},{"key":"2576_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nature13383","volume":"512","author":"L Arranz","year":"2014","unstructured":"Arranz L, Sanchez-Aguilera A, Martin-Perez D, Isern J, Langa X, Tzankov A, et al. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms. Nature. 2014;512:78\u201381.","journal-title":"Nature"},{"key":"2576_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nrc2047","volume":"7","author":"SJ Corey","year":"2007","unstructured":"Corey SJ, Minden MD, Barber DL, Kantarjian H, Wang JC, Schimmer AD. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer. 2007;7:118\u201329.","journal-title":"Nat Rev Cancer"},{"key":"2576_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s12185-012-1182-y","volume":"96","author":"S Ogawa","year":"2012","unstructured":"Ogawa S. Splicing factor mutations in myelodysplasia. Int J Hematol. 2012;96:438\u201342.","journal-title":"Int J Hematol"},{"key":"2576_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1056\/NEJMp048266","volume":"352","author":"M Cazzola","year":"2005","unstructured":"Cazzola M, Malcovati L. Myelodysplastic syndromes\u2013coping with ineffective hematopoiesis. N Engl J Med. 2005;352:536\u20138.","journal-title":"N Engl J Med"},{"key":"2576_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1590\/1414-431X20144051","volume":"48","author":"H Xiong","year":"2015","unstructured":"Xiong H, Yang XY, Han J, Wang Q, Zou ZL. Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenvironment of patients with myelodysplastic syndromes. Br J Med Biol Res. 2015;48:207\u201313.","journal-title":"Br J Med Biol Res"},{"key":"2576_CR12","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/labinvest.2014.110","volume":"94","author":"S Abe-Suzuki","year":"2014","unstructured":"Abe-Suzuki S, Kurata M, Abe S, Onishi I, Kirimura S, Nashimoto M, et al. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes. Lab Invest. 2014;94:1212\u201323.","journal-title":"Lab Invest"},{"key":"2576_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1182\/blood-2015-06-653113","volume":"127","author":"SR Balderman","year":"2016","unstructured":"Balderman SR, Li AJ, Hoffman CM, Frisch BJ, Goodman AN, LaMere MW, et al. Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome. Blood. 2016;127:616\u201325.","journal-title":"Blood"},{"key":"2576_CR14","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/labinvest.2012.93","volume":"92","author":"E Flores-Figueroa","year":"2012","unstructured":"Flores-Figueroa E, Varma S, Montgomery K, Greenberg PL, Gratzinger D. Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow. Lab Invest. 2012;92:1330\u201341.","journal-title":"Lab Invest"},{"key":"2576_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.leu.2405030","volume":"22","author":"G Buesche","year":"2008","unstructured":"Buesche G, Teoman H, Wilczak W, Ganser A, Hecker H, Wilkens L, et al. Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes. Leukemia. 2008;22:313\u201322.","journal-title":"Leukemia"},{"key":"2576_CR16","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00277-013-1776-3","volume":"92","author":"B Fu","year":"2013","unstructured":"Fu B, Ok CY, Goswami M, Xei W, Jaso JM, Muzzafar T, et al. The clinical importance of moderate\/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes. Ann Hematol. 2013;92:1335\u201343.","journal-title":"Ann Hematol"},{"key":"2576_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1385\/MO:21:4:325","volume":"21","author":"D Marisavljevic","year":"2004","unstructured":"Marisavljevic D, Rolovic Z, Cemerikic V, Boskovic D, Colovic M. Myelofibrosis in primary myelodysplastic syndromes: clinical and biological significance. Med Oncol. 2004;21:325\u201331.","journal-title":"Med Oncol"},{"key":"2576_CR18","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1200\/JCO.2008.18.2246","volume":"27","author":"MG Della Porta","year":"2009","unstructured":"Della Porta MG, Malcovati L, Boveri E, Travaglino E, Pietra D, Pascutto C, et al. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes. J Clin Oncol. 2009;27:754\u201362.","journal-title":"J Clin Oncol"},{"key":"2576_CR19","first-page":"1128","volume":"90","author":"J Thiele","year":"2005","unstructured":"Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 2005;90:1128\u201332.","journal-title":"Haematologica"},{"key":"2576_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"2576_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","volume":"38","author":"Z Yang","year":"2015","unstructured":"Yang Z, Wang KK. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015;38:364\u201374.","journal-title":"Trends Neurosci"},{"key":"2576_CR22","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.stemcr.2017.04.011","volume":"8","author":"HS Kim","year":"2017","unstructured":"Kim HS, Lee J, Lee DY, Kim YD, Kim JY, Lim HJ, et al. Schwann cell precursors from human pluripotent stem cells as a potential therapeutic target for myelin repair. Stem Cell Rep. 2017;8:1714\u201326.","journal-title":"Stem Cell Rep"},{"key":"2576_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","volume":"233","author":"A Petzold","year":"2005","unstructured":"Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci. 2005;233:183\u201398.","journal-title":"J Neurol Sci"},{"key":"2576_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/leu.2013.336","volume":"28","author":"T Haferlach","year":"2014","unstructured":"Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014;28:241\u20137.","journal-title":"Leukemia"},{"key":"2576_CR25","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1182\/blood-2016-12-754796","volume":"129","author":"T Yoshizato","year":"2017","unstructured":"Yoshizato T, Nannya Y, Atsuta Y, Shiozawa Y, Iijima-Yamashita Y, Yoshida K, et al. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. Blood. 2017;129:2347\u201358.","journal-title":"Blood"},{"key":"2576_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/ejh.12512","volume":"95","author":"J Schemenau","year":"2015","unstructured":"Schemenau J, Baldus S, Anlauf M, Reinecke P, Braunstein S, Blum S, et al. Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes. Eur J Haematol. 2015;95:181\u20139.","journal-title":"Eur J Haematol"},{"key":"2576_CR27","doi-asserted-by":"publisher","first-page":"30492","DOI":"10.18632\/oncotarget.9026","volume":"7","author":"F Ramos","year":"2016","unstructured":"Ramos F, Robledo C, Izquierdo-Garcia FM, Suarez-Vilela D, Benito R, Fuertes M, et al. Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis. Oncotarget. 2016;7:30492\u2013503.","journal-title":"Oncotarget"},{"key":"2576_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0006-8993(02)02615-X","volume":"943","author":"H Gu","year":"2002","unstructured":"Gu H, Wang S, Messam CA, Yao Z. Distribution of nestin immunoreactivity in the normal adult human forebrain. Brain Res. 2002;943:174\u201380.","journal-title":"Brain Res"},{"key":"2576_CR29","first-page":"177","volume":"25","author":"A Minovi","year":"2010","unstructured":"Minovi A, Witt M, Prescher A, Gudziol V, Dazert S, Hatt H, et al. Expression and distribution of the intermediate filament protein nestin and other stem cell related molecules in the human olfactory epithelium. Histol Histopathol. 2010;25:177\u201387.","journal-title":"Histol Histopathol"},{"key":"2576_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1158\/0008-5472.CAN-05-4571","volume":"67","author":"H Li","year":"2007","unstructured":"Li H, Cherukuri P, Li N, Cowling V, Spinella M, Cole M, et al. Nestin is expressed in the basal\/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res. 2007;67:501\u201310.","journal-title":"Cancer Res"},{"key":"2576_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2350\/06-11-0193.1","volume":"10","author":"J Perry","year":"2007","unstructured":"Perry J, Ho M, Viero S, Zheng K, Jacobs R, Thorner PS. The intermediate filament nestin is highly expressed in normal human podocytes and podocytes in glomerular disease. Pediatr Dev Pathol. 2007;10:369\u201382.","journal-title":"Pediatr Dev Pathol"},{"key":"2576_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1369\/jhc.2010.955609","volume":"58","author":"S Suzuki","year":"2010","unstructured":"Suzuki S, Namiki J, Shibata S, Mastuzaki Y, Okano H. The neural stem\/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature. J Histochem Cytochem. 2010;58:721\u201330.","journal-title":"J Histochem Cytochem"},{"key":"2576_CR33","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1002\/stem.541","volume":"28","author":"D Park","year":"2010","unstructured":"Park D, Xiang AP, Mao FF, Zhang L, Di CG, Liu XM, et al. Nestin is required for the proper self-renewal of neural stem cells. Stem Cells. 2010;28:2162\u201371.","journal-title":"Stem Cells"},{"key":"2576_CR34","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1007\/s00018-004-4144-6","volume":"61","author":"C Wiese","year":"2004","unstructured":"Wiese C, Rolletschek A, Kania G, Blyszczuk P, Tarasov KV, Tarasova Y, et al. Nestin expression\u2013a property of multi-lineage progenitor cells? Cell Mol Life Sci. 2004;61:2510\u201322.","journal-title":"Cell Mol Life Sci"},{"key":"2576_CR35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/jnen\/60.6.588","volume":"60","author":"S Vaittinen","year":"2001","unstructured":"Vaittinen S, Lukka R, Sahlgren C, Hurme T, Rantanen J, Lendahl U, et al. The expression of intermediate filament protein nestin as related to vimentin and desmin in regenerating skeletal muscle. J Neuropathol Exp Neurol. 2001;60:588\u201397.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2576_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fcell.2018.00015","volume":"6","author":"A Calderone","year":"2018","unstructured":"Calderone A. The biological role of Nestin((+))-cells in physiological and pathological cardiovascular remodeling. Front Cell Dev Biol. 2018;6:15.","journal-title":"Front Cell Dev Biol"},{"key":"2576_CR37","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/jcp.22794","volume":"227","author":"PC Beguin","year":"2012","unstructured":"Beguin PC, Gosselin H, Mamarbachi M, Calderone A. Nestin expression is lost in ventricular fibroblasts during postnatal development of the rat heart and re-expressed in scar myofibroblasts. J Cell Physiol. 2012;227:813\u201320.","journal-title":"J Cell Physiol"},{"key":"2576_CR38","doi-asserted-by":"publisher","first-page":"e0176147","DOI":"10.1371\/journal.pone.0176147","volume":"12","author":"V Hertig","year":"2017","unstructured":"Hertig V, Tardif K, Meus MA, Duquette N, Villeneuve L, Toussaint F, et al. Nestin expression is upregulated in the fibrotic rat heart and is localized in collagen-expressing mesenchymal cells and interstitial CD31(+)- cells. PLoS One. 2017;12:e0176147.","journal-title":"PLoS One"},{"key":"2576_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/(SICI)1097-4547(19990515)56:4<334::AID-JNR2>3.0.CO;2-#","volume":"56","author":"Z Dong","year":"1999","unstructured":"Dong Z, Sinanan A, Parkinson D, Parmantier E, Mirsky R, Jessen KR. Schwann cell development in embryonic mouse nerves. J Neurosci Res. 1999;56:334\u201348.","journal-title":"J Neurosci Res"},{"key":"2576_CR40","doi-asserted-by":"publisher","first-page":"e03696","DOI":"10.7554\/eLife.03696","volume":"3","author":"J Isern","year":"2014","unstructured":"Isern J, Garcia-Garcia A, Martin AM, Arranz L, Martin-Perez D, Torroja C, et al. The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function. eLife. 2014;3:e03696.","journal-title":"eLife"},{"key":"2576_CR41","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1182\/blood.V90.9.3395","volume":"90","author":"I Dybedal","year":"1997","unstructured":"Dybedal I, Guan F, Borge OJ, Veiby OP, Ramsfjell V, Nagata S, et al. Transforming growth factor-beta1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells. Blood. 1997;90:3395\u2013403.","journal-title":"Blood"},{"key":"2576_CR42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1242\/jcs.113.3.383","volume":"113","author":"P Batard","year":"2000","unstructured":"Batard P, Monier MN, Fortunel N, Ducos K, Sansilvestri-Morel P, Phan T, et al. TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci. 2000;113:383\u201390.","journal-title":"J Cell Sci"},{"key":"2576_CR43","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/08977194.2011.595714","volume":"29","author":"A Biernacka","year":"2011","unstructured":"Biernacka A, Dobaczewski M, Frangogiannis NG. TGF-beta signaling in fibrosis. Growth Factors. 2011;29:196\u2013202.","journal-title":"Growth Factors"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-018-02576-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-02576-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-02576-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T01:43:07Z","timestamp":1662774187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-018-02576-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["2576"],"URL":"https:\/\/doi.org\/10.1007\/s12185-018-02576-9","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"25 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Patients\u2019 samples are used in this work. All the patients provided written informed consent before inclusion in the study, and the study protocol was approved by the ethics committee of the University of Tsukuba Hospital, which adheres to the guidelines of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}